AstraZeneca PLC - Major Shareholding Notification 2015

National Storage Mechanism | Additional information

RNS Number : 0737P

AstraZeneca PLC

03 June 2015


For filings with the FCA include the annex
For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii		AstraZeneca plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights			X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii	The Capital Group Companies, Inc.
4. Full name of shareholder(s) (if different from 3.):iv	See Schedule A
5. Date of the transaction and date on which the threshold is crossed or reached: v	1 June 2015
6. Date on which issuer notified:	2 June 2015
7. Threshold(s) that is/are crossed or reached: vi, vii	Below 3%


8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction						Resulting situation after the triggering transaction
Number of Shares			Number of Voting Rights			Number of shares		Number of voting rights			% of voting rights x
Direct		Direct xi		Indirect xii	Direct			Indirect
Ordinary Shares (ISIN: GB0009895292)	31,704,772			31,704,772							30,437,552			2.4088%
ADRs (ISIN: US0463531089)	7,433,161			7,433,161							7,435,104			0.5884%

B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument			Expiration date xiii		Exercise/ Conversion Period xiv					Number of voting rights that may be acquired if the instrument is exercised/ converted.			% of voting rights


C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument		Exercise price		Expiration date xvii		Exercise/ Conversion period xviii			Number of voting rights instrument refers to			% of voting rights xix, xx
												Nominal			Delta


Total (A+B+C)
Number of voting rights								Percentage of voting rights
37,872,656								2.9972%


9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
See Schedule A

Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:
14. Contact name:
15. Contact telephone number:


Note: Annex should only be submitted to the FCA not the issuer
Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation
Full name (including legal form of legal entities)	The Capital Group Companies, Inc.
Contact address (registered office for legal entities)	333 South Hope Street, 55th Floor Los Angeles, California 90071
Phone number & email	(213) 615-0469 & [email protected]
Other useful information (at least legal representative for legal persons)

B: Identity of the notifier, if applicable
Full name	Christopher Aquino
Contact address	333 South Hope Street, 55th Floor Los Angeles, California 90071
Phone number & email	(213) 615-0469 & [email protected]
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)	Fax: (213) 615-4056

C: Additional information

For notes on how to complete form TR-1 please see the FCA website.

Schedule A

As of 1 June 2015

AstraZeneca PLC


	Number of Shares	Percent of Outstanding

The Capital Group Companies, Inc. ("CG") holdings	37,872,656	2.997%
Holdings by CG Management Companies and Funds:
Capital Guardian Trust Company	5,512,014	0.436%
Capital International Limited	165,100	0.013%
Capital International Sàrl	154,992	0.012%
Capital International, Inc.	72,900	0.006%
Capital Research and Management Company	31,967,650	2.530%

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLBGGDLXGGBGUX

AI assistant